These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 24718793)

  • 61. Architecture and activation of phosphatidylinositol 3-kinase related kinases.
    Imseng S; Aylett CH; Maier T
    Curr Opin Struct Biol; 2018 Apr; 49():177-189. PubMed ID: 29625383
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Thyroid hormone induces rapid activation of Akt/protein kinase B-mammalian target of rapamycin-p70S6K cascade through phosphatidylinositol 3-kinase in human fibroblasts.
    Cao X; Kambe F; Moeller LC; Refetoff S; Seo H
    Mol Endocrinol; 2005 Jan; 19(1):102-12. PubMed ID: 15388791
    [TBL] [Abstract][Full Text] [Related]  

  • 63. A diverse array of cancer-associated MTOR mutations are hyperactivating and can predict rapamycin sensitivity.
    Grabiner BC; Nardi V; Birsoy K; Possemato R; Shen K; Sinha S; Jordan A; Beck AH; Sabatini DM
    Cancer Discov; 2014 May; 4(5):554-63. PubMed ID: 24631838
    [TBL] [Abstract][Full Text] [Related]  

  • 64. An overview of rapamycin: from discovery to future perspectives.
    Yoo YJ; Kim H; Park SR; Yoon YJ
    J Ind Microbiol Biotechnol; 2017 May; 44(4-5):537-553. PubMed ID: 27613310
    [TBL] [Abstract][Full Text] [Related]  

  • 65. mTORC1 inhibition induces pain via IRS-1-dependent feedback activation of ERK.
    Melemedjian OK; Khoutorsky A; Sorge RE; Yan J; Asiedu MN; Valdez A; Ghosh S; Dussor G; Mogil JS; Sonenberg N; Price TJ
    Pain; 2013 Jul; 154(7):1080-91. PubMed ID: 23607966
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [mTORC1 and sirolimus: a link with fertility].
    Tartarin P; Froment P
    Med Sci (Paris); 2013 Feb; 29(2):200-5. PubMed ID: 23452608
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Luteinizing hormone stimulates mammalian target of rapamycin signaling in bovine luteal cells via pathways independent of AKT and mitogen-activated protein kinase: modulation of glycogen synthase kinase 3 and AMP-activated protein kinase.
    Hou X; Arvisais EW; Davis JS
    Endocrinology; 2010 Jun; 151(6):2846-57. PubMed ID: 20351317
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Cardiac PI3K-Akt impairs insulin-stimulated glucose uptake independent of mTORC1 and GLUT4 translocation.
    Zhu Y; Pereira RO; O'Neill BT; Riehle C; Ilkun O; Wende AR; Rawlings TA; Zhang YC; Zhang Q; Klip A; Shiojima I; Walsh K; Abel ED
    Mol Endocrinol; 2013 Jan; 27(1):172-84. PubMed ID: 23204326
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Hepatocyte growth factor-induced c-Src-phosphatidylinositol 3-kinase-AKT-mammalian target of rapamycin pathway inhibits dendritic cell activation by blocking IκB kinase activity.
    Singhal E; Sen P
    Int J Biochem Cell Biol; 2011 Aug; 43(8):1134-46. PubMed ID: 21536148
    [TBL] [Abstract][Full Text] [Related]  

  • 70. L-threonine regulates G1/S phase transition of mouse embryonic stem cells via PI3K/Akt, MAPKs, and mTORC pathways.
    Ryu JM; Han HJ
    J Biol Chem; 2011 Jul; 286(27):23667-78. PubMed ID: 21550972
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Regulation of mTORC1 and mTORC2 complex assembly by phosphatidic acid: competition with rapamycin.
    Toschi A; Lee E; Xu L; Garcia A; Gadir N; Foster DA
    Mol Cell Biol; 2009 Mar; 29(6):1411-20. PubMed ID: 19114562
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Inhibition of mammalian target of rapamycin activates apoptosis signal-regulating kinase 1 signaling by suppressing protein phosphatase 5 activity.
    Huang S; Shu L; Easton J; Harwood FC; Germain GS; Ichijo H; Houghton PJ
    J Biol Chem; 2004 Aug; 279(35):36490-6. PubMed ID: 15218033
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Mechanical stretch activates mammalian target of rapamycin and AMP-activated protein kinase pathways in skeletal muscle cells.
    Nakai N; Kawano F; Nakata K
    Mol Cell Biochem; 2015 Aug; 406(1-2):285-92. PubMed ID: 25971373
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Rapamycin interacts synergistically with idarubicin to induce T-leukemia cell apoptosis in vitro and in a mesenchymal stem cell simulated drug-resistant microenvironment via Akt/mammalian target of rapamycin and extracellular signal-related kinase signaling pathways.
    Wu KN; Zhao YM; He Y; Wang BS; Du KL; Fu S; Hu KM; Zhang LF; Liu LZ; Hu YX; Wang YJ; Huang H
    Leuk Lymphoma; 2014 Mar; 55(3):668-76. PubMed ID: 23741975
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Oncogenic tyrosine kinase NPM/ALK induces activation of the rapamycin-sensitive mTOR signaling pathway.
    Marzec M; Kasprzycka M; Liu X; El-Salem M; Halasa K; Raghunath PN; Bucki R; Wlodarski P; Wasik MA
    Oncogene; 2007 Aug; 26(38):5606-14. PubMed ID: 17353907
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Interpreting mammalian target of rapamycin and cell growth inhibition in a genetically engineered mouse model of Nf1-deficient astrocytes.
    Banerjee S; Gianino SM; Gao F; Christians U; Gutmann DH
    Mol Cancer Ther; 2011 Feb; 10(2):279-91. PubMed ID: 21216928
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Glucose dependence of glycogen synthase activity regulation by GSK3 and MEK/ERK inhibitors and angiotensin-(1-7) action on these pathways in cultured human myotubes.
    Montori-Grau M; Tarrats N; Osorio-Conles O; Orozco A; Serrano-Marco L; Vázquez-Carrera M; Gómez-Foix AM
    Cell Signal; 2013 May; 25(5):1318-27. PubMed ID: 23453973
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Impact of oncogenic driver mutations on feedback between the PI3K and MEK pathways in cancer cells.
    Yuen HF; Abramczyk O; Montgomery G; Chan KK; Huang YH; Sasazuki T; Shirasawa S; Gopesh S; Chan KW; Fennell D; Janne P; El-Tanani M; Murray JT
    Biosci Rep; 2012 Aug; 32(4):413-22. PubMed ID: 22668349
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Inhibition of the Mechanistic Target of Rapamycin (mTOR)-Rapamycin and Beyond.
    Lamming DW
    Cold Spring Harb Perspect Med; 2016 May; 6(5):. PubMed ID: 27048303
    [TBL] [Abstract][Full Text] [Related]  

  • 80. mTORC1 inhibition increases neurotensin secretion and gene expression through activation of the MEK/ERK/c-Jun pathway in the human endocrine cell line BON.
    Li J; Liu J; Song J; Wang X; Weiss HL; Townsend CM; Gao T; Evers BM
    Am J Physiol Cell Physiol; 2011 Jul; 301(1):C213-26. PubMed ID: 21508335
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.